Pharmacologic studies on 1-nitro-9-(5-dimethylaminopentylamino)-acridine and 1-nitro-10(3-dimethylaminopropyl)-acridone. II. Chronic action.
D000166:Acridines / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity*; D000818:Animals; D000970:Antineoplastic Agents; D001777:Blood Coagulation / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects; D004123:Dimethylamines / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D005260:Female; D006066:Gonads / Q000187:drug effects; D006410:Hematopoiesis / Q000187:drug effects; D007422:Intestines / Q000187:drug effects; D007509:Irritants; D007668:Kidney / Q000187:drug effects; D007928:Lethal Dose 50; D008099:Liver / Q000187:drug effects; D008297:Male; D009574:Nitro Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012098:Reproduction / Q000187:drug effects; D013154:Spleen / Q000187:drug effects; D013950:Thymus Gland / Q000187:drug effects; D013997:Time Factors
D000166:Acridines; D000970:Antineoplastic Agents; D004123:Dimethylamines; D007509:Irritants; D009574:Nitro Compounds